Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mohs surgeons

Archives of Dermatology

Volumn 146, Issue 11, 2010, Pages 1225-1231

  Jambusaria Pahlajani, Anokhi ^a   Hess, Stephen D ^c   Katz, Kenneth A ^a,d   Berg, Daniel ^b   Schmults, Chrysalyne D ^a,d,e  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c University of California ^*

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e Mohs Micrographic Surgery Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CHEMOSURGERY; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IN-TRANSIT METASTASIS; JOB EXPERIENCE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERINEURAL INVASION; PERIOPERATIVE PERIOD; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUESTIONNAIRE; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL CARCINOMA; TREATMENT INDICATION;

CARCINOMA, SQUAMOUS CELL; DATA COLLECTION; HUMANS; MOHS SURGERY; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PHYSICIAN'S PRACTICE PATTERNS; RADIOTHERAPY, ADJUVANT; REFERRAL AND CONSULTATION; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 78349285195     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.323     Document Type: Article

References (21)

1. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001;344(13):975-983.
2. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol. 1992;26(6):976-990.
3. Cherpelis BS, Marcusen C, Lang PG. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg. 2002;28(3):268-273.
4. Clayman GL, Lee JJ, Holsinger FC, et al. Mortality risk from squamous cell skin cancer. J Clin Oncol. 2005;23(4):759-765.
5. Brantsch KD, Meisner C, Schönfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9(8):713-720.
6. Frierson HF Jr, Cooper PH. Prognostic factors in squamous cell carcinoma of the lower lip. Hum Pathol. 1986;17(4):346-354.
7. Moore BA, Weber RS, Prieto V, et al. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope. 2005;115(9):1561-1567.
8. Mehrany K, Weenig RH, Pittelkow MR, Roenigk RK, Otley CC. High recurrence rates of squamous cell carcinoma after Mohs' surgery in patients with chronic lymphocytic leukemia. Dermatol Surg. 2005;31(1):38-42. (Pubitemid 40094060)
9. Sheil AG, Disney AP, Mathew TH, Amiss N. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant Proc. 1993;25(1, pt 2):1383-1384.
10. Veness MJ, Quinn DI, Ong CS, et al. Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience. Cancer. 1999;85(8):1758-1764.
11. Leibovitch I, Huilgol SC, Selva D, Hill D, Richards S, Paver R. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia, II: perineural invasion. J Am Acad Dermatol. 2005;53(2):261-266. (Pubitemid 40979583)
12. Goepfert H, Dichtel WJ, Medina JE, Lindberg RD, Luna MD. Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg. 1984;148(4):542-547.
13. Miller SJ. The National Comprehensive Cancer Network (NCCN) guidelines of care for nonmelanoma skin cancers. Dermatol Surg. 2000;26(3):289-292.
14. Motley R, Kersey P, Lawrence C; British Association of Dermatologists; British Association of Plastic Surgeons; Royal College of Radiologists, Faculty of Clinical Oncology. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol. 2002;146(1):18-25.
15. Stasko T, Brown MD, Carucci JA, et al; International Transplant-Skin Cancer Collaborative; European Skin Care in Organ Transplant Patients Network. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg. 2004;30(4, pt 2):642-650.
16. Breuninger H, Bootz F, Hauschild A, et al. Short German guidelines: squamous cell carcinoma. J Dtsch Dermatol Ges. 2008;6(suppl 1):S5-S8. (Pubitemid 351782280)
17. Committee on Guidelines of Care; Task Force on Cutaneous Squamous Cell Carcinoma. Guidelines for care for squamous cell carcinoma. J Am Acad Dermatol. 1993;28(4):628-631.
18. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987;317(3):141-145.
19. Ross AS, Whalen FM, Elenitsas R, Xu X, Troxel AB, Schmults CD. Diameter of involved nerves predicts outcomes in cutaneous squamous cell carcinoma with perineural invasion: an investigator-blinded retrospective cohort study. Dermatol Surg. 2009;35(12):1859-1866.
20. Jambusaria-Pahlajani A, Miller CJ, Quon H, Smith N, Klein RQ, Schmults CD. Surgical monotherapy versus surgery plus adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma: a systematic review of outcomes. Dermatol Surg. 2009;35(4):574-585.
21. Ross AS, Schmults CD. Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature. Dermatol Surg. 2006;32(11):1309-1321.